• darkblurbg

    Developing precision therapies

    for type 1 diabetes

  • darkblurbg

    Intralymphatic immunotherapy

    with Diamyd®


 Dates for financial information and other events
Data pager
Data pager
October 18 − October 22, 2021
ASHG 2021 Virtual Meeting
November 9 − November 10, 2021
Biomarkers for Rare Diseases
November 25, 2021
Erik Penser Bank Corporate Market Day
December 2, 2021
Annual General Meeting
Annual General Meeting 2020/2021
December 6 − December 11, 2021
IDF Virtual Congress 2021
International Diabetes Federation Virtual Congress

Company Presentation

 June 23, 2021

We will make sure to work closely with the FDA and other authorities to advance Diamyd® as fast as possible.

Ulf Hannelius
President and CEO, Diamyd Medical AB
CEO Comments, Year-End Report 20/21, October 13, 2021


Diamyd Medical develops therapies for type 1 diabetes
The share is listed on Nasdaq First North Growth Market (ticker: DMYD B)

Read More

Order GAD for preclinical research